There's typically 1-3 days of rest after each injection -- the treatment site may be sore as the inflammatory cascade activates

you can also search for UK trials via NIHR Be Part of Research (www.bepartofresearch.nihr.ac.uk) Do not discontinue any existing prescribed medication (such as semaglutide or tirzepatide) in anticipation of retatrutide becoming available For clinicians: Familiarise yourself with the LY3437943 development code and ongoing Phase 3 trial data, as patients may present with questions informed by media coverage Be prepared to discuss the distinction between investigational and approved therapies , and the importance of evidence-based prescribing Monitor MHRA and NICE communications for updates on regulatory submissions and technology appraisals From a safety perspective, the adverse effect profile observed in Phase 2 trials (as reported in the 2023 New England Journal of Medicine publication) was broadly consistent with other GLP-1-based therapies, with nausea, vomiting, diarrhoea, and decreased appetite being the most commonly reported side effects

Do not use if you have primary systemic carnitine deficiency or secondary carnitine deficiency (inborn errors in metabolism) for which levocarnitine supplementation is prescribed and/or monitored by a health-care practitioner

What's inside Ingredients List Water Skin Conditioning Centella Asiatica Extract 22.7% Cleansing Glycerin Humectant Cetyl Ethylhexanoate Emollient Butylene Glycol Humectant Polyglyceryl-3 Methylglucose Distearate Emulsifying Niacinamide Smoothing Stearic Acid Cleansing Sodium Polyacryloyldimethyl Taurate Emulsion Stabilising Silica Abrasive Sodium Hyaluronate Humectant Glyceryl Stearate Emollient Beeswax Emulsion Stabilising Butyrospermum Parkii Butter Skin Conditioning Macadamia Ternifolia Seed Oil Emollient Hydrogenated Polydecene Emollient Betaine Humectant Glutathione Trehalose Humectant Adenosine Skin Conditioning Citric Acid Buffering Trideceth-10 Cleansing Disodium EDTA Sodium Citrate Buffering Caprylic/Capric Triglyceride Masking Hydrogenated Lecithin Emulsifying Cholesterol Emollient Xanthan Gum Emulsifying Nelumbo Nucifera Extract Skin Conditioning Artemisia Annua Extract Masking Oryza Sativa Extract Absorbent Saccharomyces Ferment Skin Conditioning Solanum Melongena Fruit Extract Skin Conditioning Melaleuca Alternifolia Leaf Extract Perfuming Hydrolyzed Collagen Emollient Squalane Emollient Beta-Glucan Skin Conditioning Dipropylene Glycol Humectant Hippophae Rhamnoides Fruit Extract Skin Conditioning Madecassic Acid Skin Conditioning Asiaticoside Antioxidant Asiatic Acid Skin Conditioning Propanediol Solvent Hydroxyacetophenone Antioxidant 1,2-Hexanediol Skin Conditioning Ethylhexylglycerin Skin Conditioning Dipotassium Glycyrrhizate Humectant Water, Centella Asiatica Extract 22.7%, Glycerin, Cetyl Ethylhexanoate, Butylene Glycol, Polyglyceryl-3 Methylglucose Distearate, Niacinamide, Stearic Acid, Sodium Polyacryloyldimethyl Taurate, Silica, Sodium Hyaluronate, Glyceryl Stearate, Beeswax, Butyrospermum Parkii Butter, Macadamia Ternifolia Seed Oil, Hydrogenated Polydecene, Betaine, Glutathione, Trehalose, Adenosine, Citric Acid, Trideceth-10, Disodium EDTA, Sodium Citrate, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Cholesterol, Xanthan Gum, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa Extract, Saccharomyces Ferment, Solanum Melongena Fruit Extract, Melaleuca Alternifolia Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Madecassic Acid, Asiaticoside, Asiatic Acid, Propanediol, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate Key Ingredients Benefits Concerns Ingredients Explained Water

Off-Label Use: Some medications are prescribed off-label for weight loss: Semaglutide (Ozempic): FDA-approved for type 2 diabetes (not weight loss) Identical to Wegovy but different indication Commonly prescribed off-label for weight loss Same effectiveness as Wegovy Tirzepatide (Mounjaro): FDA-approved for type 2 diabetes (not weight loss) Identical to Zepbound but different indication Prescribed off-label for weight loss before Zepbound approval Same effectiveness as Zepbound Metformin: Diabetes medication sometimes used for weight loss Produces only 1-3% weight loss Not FDA-approved for weight loss Generally not recommended as primary weight loss medication The Current State of Weight Loss Medication: Clear Winners: GLP-1 receptor agonists (especially tirzepatide and semaglutide) have become the gold standard for medical weight loss, producing results previously unattainable with medication alone